Polycystic ovary syndrome.
Ehrmann
David A
DA
University of Chicago, Department of Medicine, Section of Endocrinology, Chicago, USA. dehrmann@uchicago.edu
D000152:Acne Vulgaris / Q000209:etiology; D000726:Androgen Antagonists / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D002839:Chromans / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology; D003937:Diagnosis, Differential; D004038:Diet, Reducing; D005260:Female; D018149:Glucose Intolerance / Q000150:complications / Q000188:drug therapy; D006628:Hirsutism / Q000209:etiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008687:Metformin / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D045162:Thiazolidinediones / Q000627:therapeutic use; D000077288:Troglitazone
D000726:Androgen Antagonists; D002839:Chromans; D003276:Contraceptives, Oral; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D008687:Metformin; D000077288:Troglitazone